Tag Archives: Clinical Biotechnology Research Institute: Roper St Francis Hospital

Pharmacological Treatment for Agitation in Alzheimer’s Disease? (JAMA)

Summary Combination dextromethorphan-quinidine shows early signs of being a safe and effective treatment option for Alzheimer’s Disease-related agitation. Full Text Link Reference Cummings, JL. Lyketsos, CG. [and] Peskind, ER. [et al] (2015). Effect of dextromethorphan-quinidine on agitation in patients with … Continue reading

Posted in For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Mental Health, Models of Dementia Care, Pharmacological Treatments, Quick Insights | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment